Acromesomelic dysplasia, type maroteaux caused by novel loss‐of‐function mutations of the NPR2 gene: Three case reports
- 14 November 2015
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 170 (2), 426-434
- https://doi.org/10.1002/ajmg.a.37463
Abstract
The C-type natriuretic peptide (CNP)–natriuretic peptide receptor 2 (NPR2) signaling pathway plays an important role in chondrocyte development. Homozygous loss-of-function mutations of the NPR2 gene cause acromesomelic dysplasia, type Maroteaux (AMDM). The aim of this study was to identify and characterize NPR2 loss-of-function mutations in patients with AMDM. The NPR2 gene was sequenced in three Korean patients with AMDM and functional analysis of the mutated proteins was performed in vitro. Five novel NPR2 mutations were found in the three patients: two compound heterozygous mutations [c.1231T>C (Tyr411His) and c.2761C>T (Arg921X) in Patient 1 and c.1663A>T (Lys555X) and c.1711-1G>C (M571VfsX12) in Patient 3] and a homozygous mutation [c.2762G>A (Arg921Gln) in Patient 2]. Serum NT-proCNP concentration was significantly increased in each patient compared to control subjects. Cells transfected with the expression vector of each mutant except those found in Patient 3 showed a negligible or a markedly low cGMP response after treatment with CNP. HA-tagged wild-type (wt) and HA-mutant NPR2 were expressed at comparable levels: there were two bands of ∼130 and ∼120 kDa in wt and Arg921Gln, a single ∼120 kDa band in Tyr411His, and a single ∼110 kDa in the nonsense mutant. With respect to subcellular localization, Arg921Gln as well as wt-NPR2 reached the cell surface, whereas Tyr411His and Arg921X mutants did not. The Tyr411His and Arg921X NPR2 proteins were co-localized with an endoplasmic reticulum (ER) marker and failed to traffic from the ER to the Golgi apparatus. These results are consistent with deglycosylation experiments. Tyr411His and Arg921X NPR2 are complete loss-of-function mutations, whereas Arg921Gln behaves as a receptor for CNP with limited function.Keywords
Funding Information
- National Research Foundation of Korea (NRF‐2013R1A2A2A01067398)
This publication has 28 references indexed in Scilit:
- An Overgrowth Disorder Associated with Excessive Production of cGMP Due to a Gain-of-Function Mutation of the Natriuretic Peptide Receptor 2 GenePLOS ONE, 2012
- Novel mutations in natriuretic peptide receptor-2 gene underlie acromesomelic dysplasia, type maroteauxBMC Medical Genetics, 2012
- Systemic Administration of C-Type Natriuretic Peptide as a Novel Therapeutic Strategy for Skeletal DysplasiasEndocrinology, 2009
- One step at a time: endoplasmic reticulum-associated degradationNature Reviews Molecular Cell Biology, 2008
- Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossificationDevelopmental Biology, 2008
- C-natriuretic peptide: An important regulator of cartilageMolecular Genetics and Metabolism, 2007
- ER-associated protein degradation is a common mechanism underpinning numerous monogenic diseases including Robinow syndromeHuman Molecular Genetics, 2005
- A Loss-of-Function Mutation in Natriuretic Peptide Receptor 2 (Npr2) Gene Is Responsible for Disproportionate Dwarfism in cn/cn MouseOnline Journal of Public Health Informatics, 2005
- Mutations in the Transmembrane Natriuretic Peptide Receptor NPR-B Impair Skeletal Growth and Cause Acromesomelic Dysplasia, Type MaroteauxAmerican Journal of Human Genetics, 2004
- Intestinal Secretory Defects and Dwarfism in Mice Lacking cGMP-Dependent Protein Kinase IIScience, 1996